Biomarkers and pathomechanisms in chronic lung diseases

Recruiting

• Conditions: C30-C39; J09-J18; J85-J86; J90-J94; Influenza and pneumonia; Other diseases of upper respiratory tract; Chronic lower respiratory diseases; J30-J39; J40-J47; J60-J70

• Registration Number: DRKS00028872
• Lead Sponsor: Medizinische Klinik und Poliklinik V, LMU Klinikum der Universität München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 4200

Inclusion Criteria

In order to be able to research as wide a variety of lung diseases and disease stages as possible, all patients who are treated and/or operated on as outpatients in the thoracic surgery, pneumology outpatient clinic, research outpatient clinic or in the Asklepios Fachkliniken München-Gauting are asked for their consent. This includes patients who are undergoing lung transplantation in the Thoracic Surgery Department.

The indication for a patient's treatment is based solely on clinical criteria and is independent of the patient's willingness to provide biomaterials or clinical data. Included are all patients with chronic lung disease especially patients with interstitial (ILDs), obstructive (COPD and asthma) and vascular lung disease, patients before and after lung transplantation as well as patients with COVID-19 infection and patients with tumorous lung disease.

Exclusion Criteria

Patients with active hepatitis B or C, HIV, confirmed or clinically and/or radiologically probable tuberculosis, patients without valid informed consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
o primary endpoint is planned for this study. As this is a bioarchive with clinical data and biological material samples (blood, cells, tissue, urine, BAL, etc.), no primary endpoint is to be defined. Only when a scientist submits an application and wishes to use biosamples and/or data from the bioarchive will a specific study protocol with defined target variables be drawn up.

Secondary Outcome Measures

Name	Time	Method
o secondary outcome is considered for this study.